V

Veraxa Biotech AG
D

VRXA

1.48000
USD
-0.02
(-1.33%)
مغلق
حجم التداول
50
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
209,283,563
المقالات
المزيد

العنوان: Veraxa Biotech AG

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.